William B. Hayes's most recent trade in Builders Firstsource Inc was a trade of 187 Common Stock, par value $0.01 per share done at an average price of $200.0 . Disclosure was reported to the exchange on March 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Builders FirstSource | William B. Hayes | Director | Grant, award, or other acquisition of securities at price $ 199.98 per share. | 01 Mar 2024 | 187 | 11,399 (0%) | 0% | 200.0 | 37,396 | Common Stock, par value $0.01 per share |
| Builders FirstSource | Hayes B. William | Director | Grant, award, or other acquisition of securities at price $ 139.28 per share. | 01 Dec 2023 | 269 | 11,212 (0%) | 0% | 139.3 | 37,466 | Common Stock, par value $0.01 per share |
| Builders FirstSource | William B. Hayes | Director | Grant, award, or other acquisition of securities at price $ 148.74 per share. | 01 Sep 2023 | 252 | 10,943 (0%) | 0% | 148.7 | 37,482 | Common Stock, par value $0.01 per share |
| Builders FirstSource | William B. Hayes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 1,446 | 10,691 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Builders FirstSource | William B. Hayes | Director | Grant, award, or other acquisition of securities at price $ 115.86 per share. | 01 Jun 2023 | 323 | 9,245 (0%) | 0% | 115.9 | 37,423 | Common Stock, par value $0.01 per share |
| Indaptus Therapeutics Inc | William B. Hayes | Director | 25 May 2023 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | ||
| Builders FirstSource | William B. Hayes | Director | Grant, award, or other acquisition of securities at price $ 85.76 per share. | 01 Mar 2023 | 378 | 8,922 (0%) | 0% | 85.8 | 32,417 | Common Stock, par value $0.01 per share |
| Builders FirstSource | William B. Hayes | Director | Grant, award, or other acquisition of securities at price $ 63.73 per share. | 01 Dec 2022 | 509 | 8,544 (0%) | 0% | 63.7 | 32,439 | Common Stock, par value $0.01 per share |
| Indaptus Therapeutics Inc | William B. Hayes | Director | 30 Sep 2022 | 13,750 | 13,750 | - | - | Stock Option (right to buy) | ||
| Builders FirstSource | William B. Hayes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 553 | 8,035 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Builders FirstSource | William B. Hayes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 2,722 | 7,512 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Builders FirstSource | William B. Hayes | Director | Grant, award, or other acquisition of securities at price $ 63.81 per share. | 01 Jun 2022 | 509 | 4,790 (0%) | 0% | 63.8 | 32,479 | Common Stock, par value $0.01 per share |
| Builders FirstSource | William B. Hayes | Director | Grant, award, or other acquisition of securities at price $ 73.05 per share. | 01 Mar 2022 | 444 | 4,281 (0%) | 0% | 73.0 | 32,434 | Common Stock, par value $0.01 per share |
| Builders FirstSource | William B. Hayes | Director | Grant, award, or other acquisition of securities at price $ 70.22 per share. | 01 Dec 2021 | 462 | 18,515 (0%) | 0% | 70.2 | 32,442 | Common Stock, par value $0.01 per share |